Cargando…

Long-Read Whole Genome Sequencing Elucidates the Mechanisms of Amikacin Resistance in Multidrug-Resistant Klebsiella pneumoniae Isolates Obtained from COVID-19 Patients

Klebsiella pneumoniae is a Gram-negative, encapsulated, non-motile bacterium, which represents a global challenge to public health as one of the major causes of healthcare-associated infections worldwide. In the recent decade, the World Health Organization (WHO) noticed a critically increasing rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shelenkov, Andrey, Petrova, Lyudmila, Mironova, Anna, Zamyatin, Mikhail, Akimkin, Vasiliy, Mikhaylova, Yulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598329/ https://www.ncbi.nlm.nih.gov/pubmed/36290022 http://dx.doi.org/10.3390/antibiotics11101364

Ejemplares similares

Multidrug-Resistant Proteus mirabilis Strain with Cointegrate Plasmid
por: Shelenkov, Andrey, et al.
Publicado: (2020)

Genomic Characterization of Clinical Acinetobacter baumannii Isolates Obtained from COVID-19 Patients in Russia
por: Shelenkov, Andrey, et al.
Publicado: (2022)

Diversity of International High-Risk Clones of Acinetobacter baumannii Revealed in a Russian Multidisciplinary Medical Center during 2017–2019
por: Shelenkov, Andrey, et al.
Publicado: (2021)

Genomic and Phenotypic Analysis of Multidrug-Resistant Acinetobacter baumannii Clinical Isolates Carrying Different Types of CRISPR/Cas Systems
por: Tyumentseva, Marina, et al.
Publicado: (2021)

Molecular Typing, Characterization of Antimicrobial Resistance, Virulence Profiling and Analysis of Whole-Genome Sequence of Clinical Klebsiella pneumoniae Isolates
por: Shelenkov, Andrey, et al.
Publicado: (2020)

Whole-Genome Sequencing Revealed the Fusion Plasmids Capable of Transmission and Acquisition of Both Antimicrobial Resistance and Hypervirulence Determinants in Multidrug-Resistant Klebsiella pneumoniae Isolates
por: Shelenkov, Andrey, et al.
Publicado: (2023)

CRISPR Element Patterns vs. Pathoadaptability of Clinical Pseudomonas aeruginosa Isolates from a Medical Center in Moscow, Russia
por: Tyumentseva, Marina, et al.
Publicado: (2021)

International Clones of High Risk of Acinetobacter Baumannii—Definitions, History, Properties and Perspectives
por: Shelenkov, Andrey, et al.
Publicado: (2023)

Comparative Whole-Genome Analysis of Russian Foodborne Multidrug-Resistant Salmonella Infantis Isolates
por: Egorova, Anna, et al.
Publicado: (2021)

Antimicrobial Resistance and Genomic Characterization of OXA-48- and CTX-M-15-Co-Producing Hypervirulent Klebsiella pneumoniae ST23 Recovered from Nosocomial Outbreak
por: Shaidullina, Elvira, et al.
Publicado: (2020)

Plasmid Composition, Antimicrobial Resistance and Virulence Genes Profiles of Ciprofloxacin- and Third-Generation Cephalosporin-Resistant Foodborne Salmonella enterica Isolates from Russia
por: Egorova, Anna, et al.
Publicado: (2023)

Whole-Genome Analysis of Staphylococcus aureus Isolates from Ready-to-Eat Food in Russia
por: Mikhaylova, Yulia, et al.
Publicado: (2022)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients
por: Javadi, Mohammad Reza, et al.
Publicado: (2011)

Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains
por: Rahmati, Mohamad, et al.
Publicado: (2022)

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018)

Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2015)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Efficacy of Zidovudine-Amikacin Combination Therapy In Vitro and in a Rat Tissue Cage Infection Model against Amikacin-Resistant, Multidrug-Resistant Enterobacteriales
por: Gong, Wei-Tao, et al.
Publicado: (2023)

Comparative Proteomics Demonstrates Altered Metabolism Pathways in Cotrimoxazole- Resistant and Amikacin-Resistant Klebsiella pneumoniae Isolates
por: Shen, Chunmei, et al.
Publicado: (2021)

Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2016)

Effect of Gold Nanostars Plus Amikacin against Carbapenem-Resistant Klebsiella pneumoniae Biofilms
por: Aguilera-Correa, John Jairo, et al.
Publicado: (2022)

Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis
por: de Vasconcelos, Karla Anacleto, et al.
Publicado: (2018)

Microbial Enzymatic Synthesis of Amikacin Analogs With Antibacterial Activity Against Multidrug-Resistant Pathogens
por: Ban, Yeon Hee, et al.
Publicado: (2021)

In Vitro and In Vivo Effect of Amikacin and Imipenem Combinations against Multidrug-Resistant E. coli
por: Farhan, Sara Mahmoud, et al.
Publicado: (2022)

In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia
por: Bayatinejad, Ghazal, et al.
Publicado: (2023)

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
por: Yu, Lan, et al.
Publicado: (2019)

Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
por: Ni, Wentao, et al.
Publicado: (2016)

Amikacin: Uses, Resistance, and Prospects for Inhibition
por: Ramirez, Maria S., et al.
Publicado: (2017)

Mobile Colistin Resistance Genetic Determinants of Non-Typhoid Salmonella enterica Isolates from Russia
por: Kuleshov, Konstantin V., et al.
Publicado: (2021)

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
por: Ammar, Mona Ahmed, et al.
Publicado: (2018)

The secondary resistome of multidrug-resistant Klebsiella pneumoniae
por: Jana, Bimal, et al.
Publicado: (2017)

Klebsiella species: Taxonomy, hypervirulence and multidrug resistance
por: Dong, Ning, et al.
Publicado: (2022)

Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
por: Lee, Kyungwon, et al.
Publicado: (2006)

Genomic analysis of the international high-risk clonal lineage Klebsiella pneumoniae sequence type 395
por: Shaidullina, Elvira R., et al.
Publicado: (2023)

Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae
por: Kannan, Abhilash, et al.
Publicado: (2019)

Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report
por: Li, Jiyao, et al.
Publicado: (2022)

Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates
por: Hou, Xiang-hua, et al.
Publicado: (2015)

Multidrug-Resistant Klebsiella pneumoniae Causing Severe Infections in the Neuro-ICU
por: Fursova, Nadezhda K., et al.
Publicado: (2021)

Whole-Genome Sequencing of Pathogenic Bacteria—New Insights into Antibiotic Resistance Spreading
por: Shelenkov, Andrey
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1mabd3qj15sk5m1b3ltgtrcjna